A method of cancer screening
A technology for cancer screening, applied in the field of medical molecular biology
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0067] Embodiment one material and method
[0068] 1. Test materials
[0069]The test materials included a series of complete samples of cervical lesions, including normal samples (n=45), low-grade squamous cell intraepithelial lesions (LSIL, n=45), high-grade squamous cell intraepithelial lesions (HSIL, n=58 ), squamous cell carcinoma (squamous cell carcinoma, SCC, n=109); the test materials also included a series of complete ovarian tumor samples, including ovarian benign tumor samples (n=36), ovarian borderline tumor samples (n=6), Ovarian malignant tumor samples (n=122); all cervical and ovarian samples were obtained from the Gynecological Tumor Tissue Bank of Taipei Tri-Service General Hospital, and the genomic DNA of each sample was extracted with Qiagene DNA kit and quantified by PicoGreen fluorescence absorption method DNA, and the quality of the DNA was checked by gel electrophoresis.
[0070] In addition, the liver cell samples include normal liver cell samples (n=...
Embodiment 2
[0095] Example 2 Screening of cervical cancer methylation indicator genes
[0096]Using CpG island microarrays (CpGisland microarrays) to perform differential methylation heterozygosity (DMH) to screen out genes with high methylation in cervical squamous cell carcinoma (SCC); CpG island microarrays (CpGisland microarrays) The results showed that there were 216 differentially methylated sites between cervical cancer tissue samples and normal Pap smear samples. After removing sequence repeats, 26 CpG islands (promoter CGIs) of gene activator regions were obtained.
[0097] These gene activators were sequenced and analyzed, and 6 genes were selected, including: SOX1 (SEQ ID No: 1), PAX1 (SEQ ID No: 2), LMX1A (SEQ ID No: 3), NKX6-1 (SEQ ID No: 4 ), WT1 (SEQ ID No: 5) and ONECUT1 (SEQ ID No: 6), the detailed information of which is shown in Table 4; as can be seen from Table 4, these six genes are important transcription factors (transcription factors) in the development process, S...
Embodiment 3
[0103] Example 3 Correlation between DNA methylation and gene expression in cervical cancer cell lines
[0104] In order to confirm whether the expression of cervical cancer methylation pointer genes is regulated by DNA methylation, the DNA methyltransferase inhibitor 5'-aza-2'-deoxycytidine (AZC) (SigmaChemicalCo.) was treated with 10 μM After 4 days in HeLa cervical cancer cell line, methylation-specific PCR (MSP) was used to check the demethylation of the above six gene activators; MSP primers ( U), and the MSP primer (M) that can specifically identify the sequence of the methylated gene for methylation-specific PCR (MSP), the results are as follows Figure 4A As shown, in the HeLa cervical cancer cell line (AZC-) not treated with 5'-aza-2'-deoxycytidine (AZC), all six target genes had methylation phenomenon (such as Figure 4A shown in column 1), and unmethylated genes (such as Figure 4A Shown in column 2); while in HeLa cervical cancer cell lines (AZC+) treated with 5'...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com